Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599092 · ClinicalTrials.gov registry record
Pituitary Tumor Surveillance: Pathogenic Correlation
A clinical trial of Pituitary Tumor, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- 1,250
- Enrollment target
- 1
- Study location
NCT00599092: Recruiting study of Pituitary Tumor, sponsored by Cedars-Sinai Medical Center.
NCT00599092 is a study of Pituitary Tumor that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 1,250 participants, above the 174-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (618% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599092, a study of Pituitary Tumor, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Primary Outcome
Overall survival will be measured from study enrollment (or diagnosis, as applicable) to death from any cause. Survival status will be determined through electronic medical records and, if necessary, supplemented by publicly available death records (e.g., National Death Index).
Conditions Studied
Study Locations (1)
California
- Cedars-Sinai Medical Center, Pituitary Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 1997-01 |
| Est. Completion | 2050-12 |
What NCT00599092 shows while recruiting
NCT00599092 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, above the 174-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (618% higher).
The record links to 1 condition, with Pituitary Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT00599092 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00599092 about?
NCT00599092 is a clinical study titled "Pituitary Tumor Surveillance: Pathogenic Correlation". The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
What is the current status of trial NCT00599092?
This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 1997-01. Estimated completion is 2050-12.
What conditions does trial NCT00599092 study?
This clinical trial studies the following conditions: Pituitary Tumor.
Who is sponsoring clinical trial NCT00599092?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00599092 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pituitary Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
RECRUITING · NA
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia